Claudia Wehr
Freiburg, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 56 publications
Subtype-specific outcome after allogeneic hematopoietic cell transplantation in advanced systemic mastocytosis: a registry study of the European competence network on mastocytosis.
Journal: Experimental hematology & oncology
Published: June 21, 2026
Peri-transplant ruxolitinib prophylaxis improves outcome in patients receiving allogeneic hematopoietic cell transplantation for myelofibrosis.
Journal: Transplantation and cellular therapy
Published: May 08, 2026
Peri-Transplant Ruxolitinib Prophylaxis Improves Outcome in Patients Receiving Allogeneic Hematopoietic Cell Transplantation for Myelofibrosis.
Journal: Transplantation and cellular therapy
Published: May 08, 2026
Characterisation of TP53 mutational features and outcomes of acute myeloid leukaemia after allogeneic haematopoietic cell transplantation.
Journal: Bone marrow transplantation
Published: April 27, 2026
Correction to: An international survey of allogeneic hematopoietic cell transplantation for X-linked agammaglobulinemia.
Journal: Journal of clinical immunology
Published: January 21, 2026
Donor lymphocyte infusions for recurrence of myeloid neoplasms after allogeneic hematopoietic cell transplantation in the era of hypomethylating agents and BCL2 inhibitors.
Journal: Annals of hematology
Published: December 13, 2025
Machine learning-based prediction of one-year mortality after alloHCT identifies the impact of pre-transplant immunity and inflammation.
Journal: Frontiers in immunology
Published: November 13, 2025
Mutational landscape changes of AML in patients relapsing after allogeneic hematopoietic cell transplantation.
Journal: Bone marrow transplantation
Published: September 19, 2025
Usage of rabbit anti-thymocyte / anti-T-lymphocyte globulins (ATG / ATLG) for hematological malignancies in allogeneic hematopoietic cell transplantation: Best practice recommendations from the EBMT Practice Harmonisation and Guidelines Committee.
Journal: Bone marrow transplantation
Published: August 06, 2025
Healthcare resource utilization and costs of letermovir for cytomegalovirus-prophylaxis after allogeneic hematopoietic cell transplantation in a real-world, multi-centre study in Germany.
Journal: The European journal of health economics : HEPAC : health economics in prevention and care
Published: July 08, 2025
Last Updated: 09/26/2026